Rank | Gene Set | Z-score |
---|---|---|
1 | intestinal cholesterol absorption (GO:0030299) | 4.88807526 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.46906003 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.46906003 |
4 | protein retention in ER lumen (GO:0006621) | 4.35642013 |
5 | cysteine metabolic process (GO:0006534) | 4.29912221 |
6 | sulfur amino acid catabolic process (GO:0000098) | 4.28188804 |
7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.28147033 |
8 | L-phenylalanine metabolic process (GO:0006558) | 3.98914440 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98914440 |
10 | respiratory chain complex IV assembly (GO:0008535) | 3.88510447 |
11 | L-phenylalanine catabolic process (GO:0006559) | 3.83510582 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.83510582 |
13 | xenobiotic catabolic process (GO:0042178) | 3.83185416 |
14 | valine metabolic process (GO:0006573) | 3.78929337 |
15 | cytochrome complex assembly (GO:0017004) | 3.77442324 |
16 | Golgi transport vesicle coating (GO:0048200) | 3.77142711 |
17 | COPI coating of Golgi vesicle (GO:0048205) | 3.77142711 |
18 | keratinocyte development (GO:0003334) | 3.74062428 |
19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70753245 |
20 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.67485918 |
21 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.67485918 |
22 | proteasome assembly (GO:0043248) | 3.66112208 |
23 | oligosaccharide catabolic process (GO:0009313) | 3.63425030 |
24 | serine family amino acid biosynthetic process (GO:0009070) | 3.62412974 |
25 | pentose-phosphate shunt (GO:0006098) | 3.59531123 |
26 | platelet dense granule organization (GO:0060155) | 3.52165263 |
27 | exocrine pancreas development (GO:0031017) | 3.50278574 |
28 | glycine metabolic process (GO:0006544) | 3.44436445 |
29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44156874 |
30 | keratan sulfate catabolic process (GO:0042340) | 3.43883646 |
31 | proline biosynthetic process (GO:0006561) | 3.43364659 |
32 | NADPH regeneration (GO:0006740) | 3.41154912 |
33 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.38613111 |
34 | lactate metabolic process (GO:0006089) | 3.38215709 |
35 | glutathione derivative biosynthetic process (GO:1901687) | 3.36296823 |
36 | glutathione derivative metabolic process (GO:1901685) | 3.36296823 |
37 | aromatic amino acid family catabolic process (GO:0009074) | 3.35984886 |
38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35152109 |
39 | cellular modified amino acid catabolic process (GO:0042219) | 3.34317550 |
40 | glyoxylate metabolic process (GO:0046487) | 3.29831324 |
41 | serine family amino acid metabolic process (GO:0009069) | 3.27335355 |
42 | intestinal absorption (GO:0050892) | 3.22626460 |
43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.21918359 |
44 | digestion (GO:0007586) | 3.20130039 |
45 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.18892374 |
46 | killing of cells of other organism (GO:0031640) | 3.18587179 |
47 | disruption of cells of other organism (GO:0044364) | 3.18587179 |
48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.18419845 |
49 | lysine catabolic process (GO:0006554) | 3.16009732 |
50 | lysine metabolic process (GO:0006553) | 3.16009732 |
51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15354603 |
52 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.13564024 |
53 | transcytosis (GO:0045056) | 3.08745551 |
54 | L-serine metabolic process (GO:0006563) | 3.08298187 |
55 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.05395289 |
56 | glycosphingolipid catabolic process (GO:0046479) | 3.04748281 |
57 | homocysteine metabolic process (GO:0050667) | 3.00998205 |
58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97950306 |
59 | kynurenine metabolic process (GO:0070189) | 2.97817941 |
60 | indolalkylamine catabolic process (GO:0046218) | 2.96688805 |
61 | tryptophan catabolic process (GO:0006569) | 2.96688805 |
62 | indole-containing compound catabolic process (GO:0042436) | 2.96688805 |
63 | retinal metabolic process (GO:0042574) | 2.94262751 |
64 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.92382072 |
65 | urea cycle (GO:0000050) | 2.90473306 |
66 | urea metabolic process (GO:0019627) | 2.90473306 |
67 | ethanol oxidation (GO:0006069) | 2.89947986 |
68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88153145 |
69 | protein carboxylation (GO:0018214) | 2.88153145 |
70 | cell wall macromolecule catabolic process (GO:0016998) | 2.87865679 |
71 | tryptophan metabolic process (GO:0006568) | 2.86817583 |
72 | mitochondrial calcium ion transport (GO:0006851) | 2.85985855 |
73 | serine family amino acid catabolic process (GO:0009071) | 2.83567725 |
74 | primary alcohol catabolic process (GO:0034310) | 2.81881574 |
75 | ceramide catabolic process (GO:0046514) | 2.81784740 |
76 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81070300 |
77 | bile acid biosynthetic process (GO:0006699) | 2.80714749 |
78 | amino-acid betaine metabolic process (GO:0006577) | 2.80036433 |
79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79640734 |
80 | proline metabolic process (GO:0006560) | 2.79007480 |
81 | regulation of protein glycosylation (GO:0060049) | 2.78865994 |
82 | sphingolipid catabolic process (GO:0030149) | 2.77640832 |
83 | positive regulation of protein autophosphorylation (GO:0031954) | 2.77455090 |
84 | intracellular pH reduction (GO:0051452) | 2.77399016 |
85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.76130763 |
86 | regulation of B cell apoptotic process (GO:0002902) | 2.75264891 |
87 | bile acid and bile salt transport (GO:0015721) | 2.73722459 |
88 | neutrophil activation involved in immune response (GO:0002283) | 2.73541019 |
89 | glycolipid catabolic process (GO:0019377) | 2.72719015 |
90 | membrane lipid catabolic process (GO:0046466) | 2.72362014 |
91 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71534028 |
92 | nitrogen cycle metabolic process (GO:0071941) | 2.71371148 |
93 | negative regulation of sterol transport (GO:0032372) | 2.70837189 |
94 | negative regulation of cholesterol transport (GO:0032375) | 2.70837189 |
95 | glucosamine-containing compound catabolic process (GO:1901072) | 2.70735823 |
96 | cellular ketone body metabolic process (GO:0046950) | 2.70193869 |
97 | negative regulation of complement activation (GO:0045916) | 2.69674949 |
98 | negative regulation of fibrinolysis (GO:0051918) | 2.68813690 |
99 | response to hydroperoxide (GO:0033194) | 2.68456200 |
100 | signal peptide processing (GO:0006465) | 2.65986309 |
101 | branched-chain amino acid metabolic process (GO:0009081) | 2.65725090 |
102 | high-density lipoprotein particle remodeling (GO:0034375) | 2.65164833 |
103 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.64810245 |
104 | mannosylation (GO:0097502) | 2.63764283 |
105 | C-terminal protein lipidation (GO:0006501) | 2.63531712 |
106 | nucleotide salvage (GO:0043173) | 2.63025478 |
107 | nucleoside salvage (GO:0043174) | 2.60890416 |
108 | S-adenosylmethionine metabolic process (GO:0046500) | 2.59635216 |
109 | branched-chain amino acid catabolic process (GO:0009083) | 2.58480057 |
110 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58186103 |
111 | peptide catabolic process (GO:0043171) | 2.57900716 |
112 | sphingoid metabolic process (GO:0046519) | 2.56785639 |
113 | ethanol metabolic process (GO:0006067) | 2.56007629 |
114 | positive regulation of B cell differentiation (GO:0045579) | 2.55851542 |
115 | cellular amino acid catabolic process (GO:0009063) | 2.55823070 |
116 | regulation of triglyceride catabolic process (GO:0010896) | 2.54783053 |
117 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.54400527 |
118 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.53832327 |
119 | galactose catabolic process (GO:0019388) | 2.53657162 |
120 | negative regulation of protein activation cascade (GO:2000258) | 2.52732032 |
121 | neutrophil mediated immunity (GO:0002446) | 2.52722544 |
122 | positive regulation of prostaglandin secretion (GO:0032308) | 2.51722124 |
123 | defense response to fungus (GO:0050832) | 2.51416815 |
124 | NADP metabolic process (GO:0006739) | 2.50871427 |
125 | complement activation, alternative pathway (GO:0006957) | 2.50549129 |
126 | protein-lipid complex remodeling (GO:0034368) | 2.50011662 |
127 | macromolecular complex remodeling (GO:0034367) | 2.50011662 |
128 | plasma lipoprotein particle remodeling (GO:0034369) | 2.50011662 |
129 | response to nitrosative stress (GO:0051409) | 2.49892426 |
130 | regulation of cholesterol homeostasis (GO:2000188) | 2.49309834 |
131 | DNA deamination (GO:0045006) | 2.49035411 |
132 | alpha-amino acid catabolic process (GO:1901606) | 2.48460293 |
133 | aromatic amino acid family metabolic process (GO:0009072) | 2.47129689 |
134 | ribosomal small subunit assembly (GO:0000028) | 2.47042582 |
135 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.45804084 |
136 | reverse cholesterol transport (GO:0043691) | 2.45703099 |
137 | pH reduction (GO:0045851) | 2.45667488 |
138 | regulation of protein activation cascade (GO:2000257) | 2.45034575 |
139 | bile acid metabolic process (GO:0008206) | 2.44964551 |
140 | one-carbon metabolic process (GO:0006730) | 2.44825928 |
141 | phospholipid efflux (GO:0033700) | 2.44821691 |
142 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.44801034 |
143 | drug transmembrane transport (GO:0006855) | 2.43892684 |
144 | hexose catabolic process (GO:0019320) | 2.43600140 |
145 | diol metabolic process (GO:0034311) | 2.43511764 |
146 | sphingosine metabolic process (GO:0006670) | 2.43063690 |
147 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.42960680 |
148 | ketone body metabolic process (GO:1902224) | 2.42107254 |
149 | regulation of metalloenzyme activity (GO:0048552) | 2.41247238 |
150 | vitamin biosynthetic process (GO:0009110) | 2.40670238 |
151 | retinol metabolic process (GO:0042572) | 2.39367953 |
152 | amine catabolic process (GO:0009310) | 2.39098562 |
153 | cellular biogenic amine catabolic process (GO:0042402) | 2.39098562 |
154 | prostate gland growth (GO:0060736) | 2.37401147 |
155 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.37152234 |
156 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.37152234 |
157 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.37152234 |
158 | L-ascorbic acid metabolic process (GO:0019852) | 2.35901221 |
159 | regulation of intracellular pH (GO:0051453) | 2.35550544 |
160 | transepithelial transport (GO:0070633) | 2.35400625 |
161 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.35229774 |
162 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.35229774 |
163 | negative regulation of protein autophosphorylation (GO:0031953) | 2.35135988 |
164 | iron ion import (GO:0097286) | 2.33911935 |
165 | regulation of hexokinase activity (GO:1903299) | 2.33611205 |
166 | regulation of glucokinase activity (GO:0033131) | 2.33611205 |
167 | diterpenoid biosynthetic process (GO:0016102) | 2.30411598 |
168 | indolalkylamine metabolic process (GO:0006586) | 2.30246334 |
169 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.28542967 |
170 | lytic vacuole organization (GO:0080171) | 2.27787907 |
171 | lysosome organization (GO:0007040) | 2.27787907 |
172 | ER overload response (GO:0006983) | 2.27776335 |
173 | C-terminal protein amino acid modification (GO:0018410) | 2.27564449 |
174 | regulation of cellular pH (GO:0030641) | 2.27505712 |
175 | sphingomyelin metabolic process (GO:0006684) | 2.27319024 |
176 | cell wall macromolecule metabolic process (GO:0044036) | 2.25376110 |
177 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.23528449 |
178 | glutathione biosynthetic process (GO:0006750) | 2.23365125 |
179 | short-chain fatty acid metabolic process (GO:0046459) | 2.23016408 |
180 | response to interferon-beta (GO:0035456) | 2.22446588 |
181 | terpenoid biosynthetic process (GO:0016114) | 2.21850310 |
182 | protein K6-linked ubiquitination (GO:0085020) | 2.21163220 |
183 | aldehyde catabolic process (GO:0046185) | 2.20453368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.00719996 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45856203 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.33011228 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24155884 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.03347190 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.85872825 |
7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.74315699 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.60539922 |
9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.42913089 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.39540683 |
11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35161418 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.19765015 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18510020 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17146232 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10322287 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09003860 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05041105 |
18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.01290829 |
19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.01023220 |
20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99428787 |
21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96408396 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95723655 |
23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94859748 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91585726 |
25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87789044 |
26 | MYC_22102868_ChIP-Seq_BL_Human | 1.85048616 |
27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83979404 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83139767 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82468083 |
30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76006230 |
31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.75278087 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72480067 |
33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71002583 |
34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.69391751 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66878104 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64826191 |
37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63493302 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62697125 |
39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60453488 |
40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.59337494 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57672970 |
42 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57296041 |
43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54631627 |
44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54299130 |
45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53914938 |
46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51951374 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51770125 |
48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.50199061 |
49 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.48798182 |
50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47566423 |
51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47319925 |
52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.47005194 |
53 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.46324606 |
54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.45863187 |
55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45850579 |
56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45675031 |
57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45448392 |
58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44438015 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44060601 |
60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43857621 |
61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43754002 |
62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42717330 |
63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40918933 |
64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39997806 |
65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39847989 |
66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39560578 |
67 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38802032 |
68 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38155446 |
69 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.35798201 |
70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35607337 |
71 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35306391 |
72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35221744 |
73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34815911 |
74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34464919 |
75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33033735 |
76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32782646 |
77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29638838 |
78 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27407833 |
79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27253720 |
80 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27172267 |
81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26393833 |
82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25398357 |
83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24941191 |
84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23055233 |
85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22972823 |
86 | MAF_26560356_Chip-Seq_TH1_Human | 1.22891965 |
87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22585380 |
88 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22381179 |
89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21865553 |
90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21865553 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21098696 |
92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20111918 |
93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20084033 |
94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20084033 |
95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20037160 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19645045 |
97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19336632 |
98 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19236607 |
99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18934497 |
100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18463753 |
101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18239105 |
102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18071453 |
103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17852590 |
104 | MYB_26560356_Chip-Seq_TH2_Human | 1.13834556 |
105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13590777 |
106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13285357 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12393417 |
108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11825516 |
109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11366559 |
110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10908088 |
111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10908088 |
112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09841042 |
113 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09383592 |
114 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08755531 |
115 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08696125 |
116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08300067 |
117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08109258 |
118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07809266 |
119 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.07530777 |
120 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07122214 |
121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07073026 |
122 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.06733990 |
123 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06687223 |
124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06555029 |
125 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06377727 |
126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06377727 |
127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05385003 |
128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04919525 |
129 | MYB_26560356_Chip-Seq_TH1_Human | 1.04886884 |
130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04436174 |
131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03743407 |
132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03480300 |
133 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03239536 |
134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02887022 |
135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02810437 |
136 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02106800 |
137 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01669563 |
138 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01620325 |
139 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.00793203 |
140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99838320 |
141 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99481776 |
142 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99416341 |
143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99244257 |
144 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98604955 |
145 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98548473 |
146 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98447672 |
147 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.97799306 |
148 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97510125 |
149 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97504823 |
150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97439390 |
151 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95058777 |
152 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94533020 |
153 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93838059 |
154 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93793960 |
155 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93738715 |
156 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93685262 |
157 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93533511 |
158 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.93489393 |
159 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93417394 |
160 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93208088 |
161 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92767877 |
162 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92661338 |
163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92029745 |
164 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91828971 |
165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91729834 |
166 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90757006 |
167 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90079515 |
168 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89990834 |
169 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.89813661 |
170 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89075314 |
171 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89045361 |
172 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88847819 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005365_abnormal_bile_salt | 4.33379847 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.24904421 |
3 | MP0005360_urolithiasis | 4.12422256 |
4 | MP0001666_abnormal_nutrient_absorption | 3.92111542 |
5 | MP0005083_abnormal_biliary_tract | 3.54632049 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.43459952 |
7 | MP0003806_abnormal_nucleotide_metabolis | 2.71772164 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49934664 |
9 | MP0009840_abnormal_foam_cell | 2.43526083 |
10 | MP0005220_abnormal_exocrine_pancreas | 2.27307207 |
11 | MP0005058_abnormal_lysosome_morphology | 2.24279028 |
12 | MP0010234_abnormal_vibrissa_follicle | 2.22009124 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.18176517 |
14 | MP0001835_abnormal_antigen_presentation | 2.12702449 |
15 | MP0003436_decreased_susceptibility_to | 2.06851805 |
16 | MP0002876_abnormal_thyroid_physiology | 2.06843061 |
17 | MP0003868_abnormal_feces_composition | 1.99676872 |
18 | MP0010329_abnormal_lipoprotein_level | 1.97776201 |
19 | MP0010386_abnormal_urinary_bladder | 1.97109942 |
20 | MP0005408_hypopigmentation | 1.96706927 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 1.95884836 |
22 | MP0003252_abnormal_bile_duct | 1.94526029 |
23 | MP0000372_irregular_coat_pigmentation | 1.84851853 |
24 | MP0001873_stomach_inflammation | 1.81479925 |
25 | MP0005075_abnormal_melanosome_morpholog | 1.81362160 |
26 | MP0009785_altered_susceptibility_to | 1.74992495 |
27 | MP0005332_abnormal_amino_acid | 1.73513646 |
28 | MP0000427_abnormal_hair_cycle | 1.70647518 |
29 | MP0000685_abnormal_immune_system | 1.67953521 |
30 | MP0002090_abnormal_vision | 1.67217305 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.64598321 |
32 | MP0005646_abnormal_pituitary_gland | 1.62220797 |
33 | MP0005464_abnormal_platelet_physiology | 1.60795288 |
34 | MP0000490_abnormal_crypts_of | 1.56557956 |
35 | MP0000609_abnormal_liver_physiology | 1.54386702 |
36 | MP0002396_abnormal_hematopoietic_system | 1.52728352 |
37 | MP0002837_dystrophic_cardiac_calcinosis | 1.50993457 |
38 | MP0005084_abnormal_gallbladder_morpholo | 1.50828098 |
39 | MP0003656_abnormal_erythrocyte_physiolo | 1.49255890 |
40 | MP0005025_abnormal_response_to | 1.48620216 |
41 | MP0003186_abnormal_redox_activity | 1.48047894 |
42 | MP0005379_endocrine/exocrine_gland_phen | 1.46574910 |
43 | MP0005319_abnormal_enzyme/_coenzyme | 1.45519670 |
44 | MP0010678_abnormal_skin_adnexa | 1.44702485 |
45 | MP0009643_abnormal_urine_homeostasis | 1.44009055 |
46 | MP0009697_abnormal_copulation | 1.40642362 |
47 | MP0010155_abnormal_intestine_physiology | 1.40394074 |
48 | MP0008469_abnormal_protein_level | 1.39918273 |
49 | MP0008004_abnormal_stomach_pH | 1.39875935 |
50 | MP0004264_abnormal_extraembryonic_tissu | 1.39707691 |
51 | MP0003300_gastrointestinal_ulcer | 1.38953453 |
52 | MP0002166_altered_tumor_susceptibility | 1.38353420 |
53 | MP0002419_abnormal_innate_immunity | 1.38336541 |
54 | MP0003172_abnormal_lysosome_physiology | 1.37185444 |
55 | MP0002118_abnormal_lipid_homeostasis | 1.33925571 |
56 | MP0003303_peritoneal_inflammation | 1.33723786 |
57 | MP0001845_abnormal_inflammatory_respons | 1.31283527 |
58 | MP0003950_abnormal_plasma_membrane | 1.29917904 |
59 | MP0001756_abnormal_urination | 1.28970841 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.27718872 |
61 | MP0004019_abnormal_vitamin_homeostasis | 1.27575423 |
62 | MP0004381_abnormal_hair_follicle | 1.26903472 |
63 | MP0006054_spinal_hemorrhage | 1.25363186 |
64 | MP0006036_abnormal_mitochondrial_physio | 1.24734094 |
65 | MP0004147_increased_porphyrin_level | 1.22410473 |
66 | MP0003724_increased_susceptibility_to | 1.21889516 |
67 | MP0003786_premature_aging | 1.21752771 |
68 | MP0000015_abnormal_ear_pigmentation | 1.20949485 |
69 | MP0006082_CNS_inflammation | 1.20791551 |
70 | MP0003183_abnormal_peptide_metabolism | 1.19307147 |
71 | MP0004947_skin_inflammation | 1.17412003 |
72 | MP0000598_abnormal_liver_morphology | 1.17157111 |
73 | MP0005671_abnormal_response_to | 1.13197794 |
74 | MP0001764_abnormal_homeostasis | 1.12493610 |
75 | MP0005310_abnormal_salivary_gland | 1.11664477 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.11226765 |
77 | MP0000371_diluted_coat_color | 1.11142046 |
78 | MP0005000_abnormal_immune_tolerance | 1.10940968 |
79 | MP0003866_abnormal_defecation | 1.09293717 |
80 | MP0004883_abnormal_blood_vessel | 1.09230211 |
81 | MP0002452_abnormal_antigen_presenting | 1.08579383 |
82 | MP0002723_abnormal_immune_serum | 1.08245857 |
83 | MP0001800_abnormal_humoral_immune | 1.08220526 |
84 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08157504 |
85 | MP0003075_altered_response_to | 1.07987793 |
86 | MP0000569_abnormal_digit_pigmentation | 1.07407612 |
87 | MP0001663_abnormal_digestive_system | 1.06993257 |
88 | MP0010307_abnormal_tumor_latency | 1.06026561 |
89 | MP0005367_renal/urinary_system_phenotyp | 1.05654068 |
90 | MP0000516_abnormal_urinary_system | 1.05654068 |
91 | MP0008872_abnormal_physiological_respon | 1.04789749 |
92 | MP0002420_abnormal_adaptive_immunity | 1.04741891 |
93 | MP0005397_hematopoietic_system_phenotyp | 1.04137840 |
94 | MP0001545_abnormal_hematopoietic_system | 1.04137840 |
95 | MP0005410_abnormal_fertilization | 1.03953619 |
96 | MP0005636_abnormal_mineral_homeostasis | 1.03560241 |
97 | MP0001819_abnormal_immune_cell | 1.03028645 |
98 | MP0003763_abnormal_thymus_physiology | 1.02803950 |
99 | MP0002405_respiratory_system_inflammati | 1.02623100 |
100 | MP0005451_abnormal_body_composition | 1.01844456 |
101 | MP0001853_heart_inflammation | 1.01554158 |
102 | MP0005164_abnormal_response_to | 1.00760199 |
103 | MP0008995_early_reproductive_senescence | 1.00170726 |
104 | MP0000689_abnormal_spleen_morphology | 0.99617636 |
105 | MP0000858_altered_metastatic_potential | 0.97778567 |
106 | MP0001533_abnormal_skeleton_physiology | 0.96846083 |
107 | MP0002148_abnormal_hypersensitivity_rea | 0.95178275 |
108 | MP0005165_increased_susceptibility_to | 0.93451566 |
109 | MP0003638_abnormal_response/metabolism_ | 0.93411418 |
110 | MP0003693_abnormal_embryo_hatching | 0.92201355 |
111 | MP0000613_abnormal_salivary_gland | 0.90651091 |
112 | MP0001881_abnormal_mammary_gland | 0.90330592 |
113 | MP0002398_abnormal_bone_marrow | 0.89682959 |
114 | MP0000604_amyloidosis | 0.89575968 |
115 | MP0005647_abnormal_sex_gland | 0.89293316 |
116 | MP0009763_increased_sensitivity_to | 0.88578571 |
117 | MP0002006_tumorigenesis | 0.87913542 |
118 | MP0005387_immune_system_phenotype | 0.87690335 |
119 | MP0001790_abnormal_immune_system | 0.87690335 |
120 | MP0000538_abnormal_urinary_bladder | 0.87466289 |
121 | MP0002138_abnormal_hepatobiliary_system | 0.86603365 |
122 | MP0001664_abnormal_digestion | 0.86443727 |
123 | MP0009333_abnormal_splenocyte_physiolog | 0.86363944 |
124 | MP0000716_abnormal_immune_system | 0.85837768 |
125 | MP0002277_abnormal_respiratory_mucosa | 0.85790101 |
126 | MP0005166_decreased_susceptibility_to | 0.85751815 |
127 | MP0003195_calcinosis | 0.85431182 |
128 | MP0005174_abnormal_tail_pigmentation | 0.84796083 |
129 | MP0009764_decreased_sensitivity_to | 0.84732735 |
130 | MP0002722_abnormal_immune_system | 0.84593377 |
131 | MP0000477_abnormal_intestine_morphology | 0.84547287 |
132 | MP0002429_abnormal_blood_cell | 0.83196200 |
133 | MP0000383_abnormal_hair_follicle | 0.81868515 |
134 | MP0009642_abnormal_blood_homeostasis | 0.81096199 |
135 | MP0004808_abnormal_hematopoietic_stem | 0.80942650 |
136 | MP0002132_abnormal_respiratory_system | 0.80309864 |
137 | MP0001986_abnormal_taste_sensitivity | 0.80112800 |
138 | MP0002693_abnormal_pancreas_physiology | 0.79144041 |
139 | MP0000343_altered_response_to | 0.78157319 |
140 | MP0003959_abnormal_lean_body | 0.77837079 |
141 | MP0003566_abnormal_cell_adhesion | 0.77817156 |
142 | MP0002254_reproductive_system_inflammat | 0.77420138 |
143 | MP0002168_other_aberrant_phenotype | 0.76824917 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.79920045 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.79920045 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.79920045 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.67672511 |
5 | Vacuolated lymphocytes (HP:0001922) | 3.93193291 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57797433 |
7 | Intrahepatic cholestasis (HP:0001406) | 3.41534285 |
8 | Fat malabsorption (HP:0002630) | 3.37774521 |
9 | Xanthomatosis (HP:0000991) | 3.34042190 |
10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32025594 |
11 | Hypobetalipoproteinemia (HP:0003563) | 3.18511321 |
12 | Tongue fasciculations (HP:0001308) | 3.16321726 |
13 | Deep venous thrombosis (HP:0002625) | 3.16071878 |
14 | Steatorrhea (HP:0002570) | 3.10843428 |
15 | Dysostosis multiplex (HP:0000943) | 3.04816301 |
16 | Prostate neoplasm (HP:0100787) | 2.99100860 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 2.97643379 |
18 | Thrombocytosis (HP:0001894) | 2.96425268 |
19 | Ketosis (HP:0001946) | 2.93426104 |
20 | Reduced antithrombin III activity (HP:0001976) | 2.90907982 |
21 | Albinism (HP:0001022) | 2.90382339 |
22 | Hypoglycemic coma (HP:0001325) | 2.89223080 |
23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86351695 |
24 | Mucopolysacchariduria (HP:0008155) | 2.86351695 |
25 | Loss of speech (HP:0002371) | 2.81761859 |
26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80515063 |
27 | Hyperammonemia (HP:0001987) | 2.79735766 |
28 | Hypothermia (HP:0002045) | 2.75873469 |
29 | Muscle fibrillation (HP:0010546) | 2.65030544 |
30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61324429 |
31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61324429 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61324429 |
33 | Hyperlipoproteinemia (HP:0010980) | 2.60663813 |
34 | Hyperglycinuria (HP:0003108) | 2.59981348 |
35 | Prolonged partial thromboplastin time (HP:0003645) | 2.59233996 |
36 | Abnormal cartilage morphology (HP:0002763) | 2.56847995 |
37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55475221 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55188267 |
39 | Complement deficiency (HP:0004431) | 2.53811248 |
40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51351193 |
41 | Late onset (HP:0003584) | 2.48719400 |
42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46757137 |
43 | Ketoacidosis (HP:0001993) | 2.46341739 |
44 | Hyperglycinemia (HP:0002154) | 2.45422276 |
45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45396057 |
46 | Recurrent bacterial skin infections (HP:0005406) | 2.44047922 |
47 | Joint hemorrhage (HP:0005261) | 2.43669712 |
48 | Eczematoid dermatitis (HP:0000976) | 2.41304692 |
49 | Beaking of vertebral bodies (HP:0004568) | 2.40402908 |
50 | Hypokinesia (HP:0002375) | 2.38632296 |
51 | Recurrent abscess formation (HP:0002722) | 2.36190578 |
52 | Increased CSF protein (HP:0002922) | 2.34459506 |
53 | Dicarboxylic aciduria (HP:0003215) | 2.34221822 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34221822 |
55 | Abnormality of glycine metabolism (HP:0010895) | 2.32537870 |
56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32537870 |
57 | Posterior subcapsular cataract (HP:0007787) | 2.30881577 |
58 | Generalized aminoaciduria (HP:0002909) | 2.30165480 |
59 | Increased cerebral lipofuscin (HP:0011813) | 2.29384108 |
60 | Thoracic kyphosis (HP:0002942) | 2.28560195 |
61 | Gout (HP:0001997) | 2.28045376 |
62 | Abnormality of dental color (HP:0011073) | 2.26803019 |
63 | IgM deficiency (HP:0002850) | 2.26741519 |
64 | Chronic otitis media (HP:0000389) | 2.26404122 |
65 | Abnormality of the thoracic spine (HP:0100711) | 2.26367356 |
66 | Pancreatitis (HP:0001733) | 2.26227030 |
67 | Abnormality of complement system (HP:0005339) | 2.25380930 |
68 | Type I transferrin isoform profile (HP:0003642) | 2.21389770 |
69 | Flat acetabular roof (HP:0003180) | 2.21223343 |
70 | Hepatic necrosis (HP:0002605) | 2.19977273 |
71 | Myocardial infarction (HP:0001658) | 2.19963899 |
72 | Systemic lupus erythematosus (HP:0002725) | 2.18497040 |
73 | Petechiae (HP:0000967) | 2.17998165 |
74 | Cutaneous melanoma (HP:0012056) | 2.16783618 |
75 | Disinhibition (HP:0000734) | 2.15958085 |
76 | Hypolipoproteinemia (HP:0010981) | 2.15158000 |
77 | Epistaxis (HP:0000421) | 2.14884877 |
78 | Progressive macrocephaly (HP:0004481) | 2.13852465 |
79 | Abnormality of the prostate (HP:0008775) | 2.13773677 |
80 | Spastic diplegia (HP:0001264) | 2.13467106 |
81 | Increased CSF lactate (HP:0002490) | 2.11748306 |
82 | Hematochezia (HP:0002573) | 2.11427064 |
83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11239158 |
84 | Pustule (HP:0200039) | 2.11132728 |
85 | Methylmalonic aciduria (HP:0012120) | 2.10822820 |
86 | Progressive neurologic deterioration (HP:0002344) | 2.10540421 |
87 | Acute encephalopathy (HP:0006846) | 2.08353612 |
88 | Hyperbilirubinemia (HP:0002904) | 2.07763057 |
89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06490708 |
90 | Mutism (HP:0002300) | 2.06417570 |
91 | Urticaria (HP:0001025) | 2.05398068 |
92 | Abnormality of T cell physiology (HP:0011840) | 2.04913795 |
93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04722594 |
94 | Abnormal platelet function (HP:0011869) | 2.04672183 |
95 | Impaired platelet aggregation (HP:0003540) | 2.04672183 |
96 | Mitochondrial inheritance (HP:0001427) | 2.04551401 |
97 | Disproportionate short-trunk short stature (HP:0003521) | 2.03398766 |
98 | Abnormal tarsal ossification (HP:0008369) | 2.02655167 |
99 | Abnormality of purine metabolism (HP:0004352) | 2.02613839 |
100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02177946 |
101 | Breast carcinoma (HP:0003002) | 2.01425668 |
102 | Joint stiffness (HP:0001387) | 2.00404953 |
103 | Malnutrition (HP:0004395) | 2.00324839 |
104 | Hepatocellular necrosis (HP:0001404) | 1.99540757 |
105 | Abdominal distention (HP:0003270) | 1.98665520 |
106 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98620601 |
107 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98620601 |
108 | Abnormal protein glycosylation (HP:0012346) | 1.98620601 |
109 | Abnormal glycosylation (HP:0012345) | 1.98620601 |
110 | Periodontitis (HP:0000704) | 1.97892733 |
111 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97559938 |
112 | Respiratory failure (HP:0002878) | 1.96998691 |
113 | Gingival bleeding (HP:0000225) | 1.96100603 |
114 | Acute necrotizing encephalopathy (HP:0006965) | 1.95270352 |
115 | Hypoplasia of the odontoid process (HP:0003311) | 1.94833974 |
116 | Cardiomegaly (HP:0001640) | 1.94096224 |
117 | Symptomatic seizures (HP:0011145) | 1.92045511 |
118 | Pancreatic cysts (HP:0001737) | 1.92040002 |
119 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91936213 |
120 | Hydroxyprolinuria (HP:0003080) | 1.91664729 |
121 | Abnormality of proline metabolism (HP:0010907) | 1.91664729 |
122 | Hypoglycemic seizures (HP:0002173) | 1.91612043 |
123 | Myositis (HP:0100614) | 1.90624646 |
124 | Menorrhagia (HP:0000132) | 1.90448940 |
125 | Glomerulonephritis (HP:0000099) | 1.89674053 |
126 | Opisthotonus (HP:0002179) | 1.89604024 |
127 | Epidermoid cyst (HP:0200040) | 1.89444921 |
128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.89277500 |
129 | Hypercholesterolemia (HP:0003124) | 1.88781170 |
130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88158583 |
131 | Methylmalonic acidemia (HP:0002912) | 1.88056438 |
132 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87452136 |
133 | Abnormality of macrophages (HP:0004311) | 1.85544495 |
134 | Esophageal varix (HP:0002040) | 1.85501441 |
135 | Interstitial pulmonary disease (HP:0006530) | 1.85163658 |
136 | Hypoplasia of the fovea (HP:0007750) | 1.83922449 |
137 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.83922449 |
138 | Autoimmune thrombocytopenia (HP:0001973) | 1.83603289 |
139 | Patchy hypopigmentation of hair (HP:0011365) | 1.82301863 |
140 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81521071 |
141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81260167 |
142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80937651 |
143 | Abnormality of methionine metabolism (HP:0010901) | 1.80701869 |
144 | Thrombophlebitis (HP:0004418) | 1.80076641 |
145 | Stomatitis (HP:0010280) | 1.78334160 |
146 | Hypophosphatemic rickets (HP:0004912) | 1.76472380 |
147 | Conjunctival hamartoma (HP:0100780) | 1.76007117 |
148 | Multiple enchondromatosis (HP:0005701) | 1.75995615 |
149 | Lethargy (HP:0001254) | 1.75948465 |
150 | Glycosuria (HP:0003076) | 1.75860989 |
151 | Abnormality of urine glucose concentration (HP:0011016) | 1.75860989 |
152 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75409649 |
153 | Thyroiditis (HP:0100646) | 1.74687198 |
154 | Hyperglycemia (HP:0003074) | 1.74184848 |
155 | Abnormality of iron homeostasis (HP:0011031) | 1.73981227 |
156 | Large for gestational age (HP:0001520) | 1.73639170 |
157 | Abnormality of the basal ganglia (HP:0002134) | 1.73148692 |
158 | Azoospermia (HP:0000027) | 1.70118744 |
159 | Renal Fanconi syndrome (HP:0001994) | 1.69632162 |
160 | Abnormality of macular pigmentation (HP:0008002) | 1.68707382 |
161 | Hamartoma of the eye (HP:0010568) | 1.67751258 |
162 | Vascular calcification (HP:0004934) | 1.67300033 |
163 | True hermaphroditism (HP:0010459) | 1.66003739 |
164 | Alopecia of scalp (HP:0002293) | 1.65100578 |
165 | Retinal atrophy (HP:0001105) | 1.63401113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 5.66363515 |
2 | MST4 | 5.15571176 |
3 | BCKDK | 4.26551797 |
4 | ERN1 | 4.14495917 |
5 | NME2 | 2.93706740 |
6 | FLT3 | 2.88463454 |
7 | MAP3K12 | 2.83781309 |
8 | EEF2K | 2.75618296 |
9 | PKN2 | 2.59660687 |
10 | TRIB3 | 2.59460089 |
11 | KIT | 2.43836465 |
12 | FER | 2.40197347 |
13 | NUAK1 | 2.31813529 |
14 | TRIM28 | 2.28372849 |
15 | MAP4K1 | 2.25871460 |
16 | STK39 | 2.24876137 |
17 | OXSR1 | 2.17791190 |
18 | BMPR1B | 2.01340765 |
19 | GRK1 | 1.98845637 |
20 | MAPKAPK3 | 1.98018218 |
21 | ZAP70 | 1.87073822 |
22 | BMPR2 | 1.84495762 |
23 | MAP4K2 | 1.81503492 |
24 | ADRBK2 | 1.71124401 |
25 | TBK1 | 1.70429576 |
26 | CSF1R | 1.68009743 |
27 | SCYL2 | 1.65327799 |
28 | MAP2K3 | 1.64411089 |
29 | TYK2 | 1.61297846 |
30 | SIK1 | 1.60901345 |
31 | ERBB3 | 1.60723087 |
32 | PIM2 | 1.58907672 |
33 | EIF2AK3 | 1.56384758 |
34 | FGFR4 | 1.53703055 |
35 | LRRK2 | 1.46119863 |
36 | EPHA2 | 1.44062208 |
37 | INSRR | 1.42767710 |
38 | BTK | 1.41298182 |
39 | GRK6 | 1.39745702 |
40 | PTK6 | 1.35789296 |
41 | SIK3 | 1.33998045 |
42 | IRAK4 | 1.28548852 |
43 | TGFBR1 | 1.27257804 |
44 | PLK2 | 1.24914679 |
45 | MAP2K2 | 1.24097717 |
46 | PRKCI | 1.23954246 |
47 | MATK | 1.22611133 |
48 | MKNK2 | 1.20698839 |
49 | MUSK | 1.16239860 |
50 | STK10 | 1.15996041 |
51 | VRK2 | 1.14548387 |
52 | STK38L | 1.13295725 |
53 | RPS6KA4 | 1.12139571 |
54 | RIPK1 | 1.10584615 |
55 | PAK3 | 1.08063745 |
56 | BLK | 1.07972498 |
57 | MAP3K11 | 1.06591253 |
58 | JAK3 | 1.04618632 |
59 | IKBKE | 1.03466884 |
60 | ACVR1B | 1.02810695 |
61 | TESK2 | 1.02536750 |
62 | KDR | 1.01374998 |
63 | PIK3CG | 1.00725292 |
64 | TEC | 0.98858110 |
65 | ZAK | 0.98611749 |
66 | MAP3K10 | 0.98400647 |
67 | PDK2 | 0.98212673 |
68 | WNK3 | 0.96038685 |
69 | MAP2K6 | 0.95454049 |
70 | TGFBR2 | 0.95052476 |
71 | CASK | 0.93455093 |
72 | PAK4 | 0.93059344 |
73 | STK3 | 0.92906318 |
74 | PIK3CA | 0.92770619 |
75 | RPS6KB2 | 0.92496584 |
76 | EIF2AK1 | 0.91893994 |
77 | PLK3 | 0.91258526 |
78 | GRK7 | 0.89073068 |
79 | PRKG2 | 0.88621318 |
80 | MYLK | 0.88609093 |
81 | MAP3K8 | 0.87425025 |
82 | PRKCE | 0.85321727 |
83 | BCR | 0.85309848 |
84 | MAPK11 | 0.80859290 |
85 | TAOK1 | 0.79795295 |
86 | IRAK3 | 0.79381742 |
87 | FRK | 0.78156059 |
88 | TESK1 | 0.77942476 |
89 | PBK | 0.77866716 |
90 | CSNK1G3 | 0.77137041 |
91 | MAP3K2 | 0.76716529 |
92 | MAP3K3 | 0.75838748 |
93 | LMTK2 | 0.74980753 |
94 | SYK | 0.74809425 |
95 | CSNK1G1 | 0.73851115 |
96 | CDK19 | 0.72210128 |
97 | FGFR2 | 0.71754630 |
98 | EIF2AK2 | 0.71433272 |
99 | TNIK | 0.70352047 |
100 | WEE1 | 0.69053748 |
101 | AKT3 | 0.69007186 |
102 | BUB1 | 0.67813462 |
103 | TAOK2 | 0.67377892 |
104 | CSNK1A1L | 0.66260762 |
105 | MST1R | 0.64070661 |
106 | ABL1 | 0.63613901 |
107 | STK16 | 0.61281529 |
108 | LYN | 0.56723978 |
109 | MAPK15 | 0.55899036 |
110 | ITK | 0.55680363 |
111 | PTK2 | 0.54717495 |
112 | DAPK1 | 0.54095193 |
113 | JAK2 | 0.53845662 |
114 | CSK | 0.53813375 |
115 | PIM1 | 0.53709420 |
116 | PASK | 0.53515746 |
117 | MKNK1 | 0.53368418 |
118 | STK24 | 0.52658503 |
119 | DYRK1B | 0.51451987 |
120 | BRSK2 | 0.50415565 |
121 | LIMK1 | 0.50130134 |
122 | CSNK1G2 | 0.48524347 |
123 | CDK8 | 0.47868199 |
124 | MAP3K6 | 0.47743073 |
125 | JAK1 | 0.47369471 |
126 | CDK6 | 0.47210266 |
127 | MAPKAPK5 | 0.45764362 |
128 | ILK | 0.45485251 |
129 | CDK7 | 0.44762351 |
130 | NEK1 | 0.44652570 |
131 | MARK3 | 0.43876159 |
132 | CHUK | 0.43658417 |
133 | LCK | 0.43624077 |
134 | RAF1 | 0.43174189 |
135 | PINK1 | 0.41613845 |
136 | EPHB1 | 0.40725841 |
137 | IGF1R | 0.40568306 |
138 | ABL2 | 0.40512592 |
139 | CDK4 | 0.40432299 |
140 | EPHB2 | 0.39775262 |
141 | MAPK4 | 0.39276056 |
142 | PAK2 | 0.37706910 |
143 | DYRK3 | 0.37551359 |
144 | MAP3K14 | 0.37506078 |
145 | ADRBK1 | 0.37405562 |
146 | MAP3K5 | 0.36262187 |
147 | CAMKK2 | 0.35654386 |
148 | IKBKB | 0.35246340 |
149 | PRKCQ | 0.33948948 |
150 | TNK2 | 0.32868325 |
151 | MAP3K13 | 0.32797124 |
152 | MAP3K1 | 0.32078437 |
153 | ARAF | 0.31845007 |
154 | HCK | 0.31335124 |
155 | CAMK2D | 0.31251210 |
156 | NEK9 | 0.30966120 |
157 | GSK3A | 0.30867828 |
158 | AURKB | 0.30830156 |
159 | ROCK1 | 0.30611296 |
160 | FGFR3 | 0.30472608 |
161 | NLK | 0.30333777 |
162 | TAF1 | 0.29280981 |
163 | PHKG2 | 0.29133831 |
164 | TRPM7 | 0.26489711 |
165 | MAP2K1 | 0.25647045 |
166 | PRKCD | 0.23534576 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 2.91013092 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89375523 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.78040389 |
4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.63610513 |
5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.45383973 |
6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25978895 |
7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.19060602 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10441719 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09873037 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07397336 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01711211 |
12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94119499 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89170472 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85053288 |
15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75212492 |
16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74290697 |
17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73897000 |
18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.69397093 |
19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.68029063 |
20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67387454 |
21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65357983 |
22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63938399 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63860630 |
24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62948090 |
25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62158307 |
26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57306187 |
27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56781833 |
28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55378584 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53891171 |
30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51387055 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.45601897 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45471725 |
33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45114099 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43535801 |
35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43015928 |
36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42477000 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40674770 |
38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40525055 |
39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39809502 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39339444 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38807520 |
42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37977515 |
43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37961536 |
44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37037078 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35669030 |
46 | Mineral absorption_Homo sapiens_hsa04978 | 1.32817144 |
47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30312950 |
48 | Protein export_Homo sapiens_hsa03060 | 1.29944292 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28565577 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27754189 |
51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.27695728 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26106306 |
53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25630310 |
54 | Asthma_Homo sapiens_hsa05310 | 1.24385349 |
55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.19369071 |
56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18669089 |
57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18566018 |
58 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17487509 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15002242 |
60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11038906 |
61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09015485 |
62 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06332556 |
63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05129090 |
64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05023186 |
65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04629120 |
66 | Lysosome_Homo sapiens_hsa04142 | 1.02948015 |
67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02041050 |
68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01356598 |
69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01057639 |
70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99770424 |
71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98585266 |
72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98344900 |
73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97658708 |
74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97580748 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96411682 |
76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91541198 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91222029 |
78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91198937 |
79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89843335 |
80 | Legionellosis_Homo sapiens_hsa05134 | 0.88693699 |
81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87366250 |
82 | Bile secretion_Homo sapiens_hsa04976 | 0.87130189 |
83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85297212 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.83634963 |
85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82292206 |
86 | Ribosome_Homo sapiens_hsa03010 | 0.81721426 |
87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80187239 |
88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79104680 |
89 | DNA replication_Homo sapiens_hsa03030 | 0.78362489 |
90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78317792 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78263142 |
92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78005594 |
93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77804969 |
94 | Homologous recombination_Homo sapiens_hsa03440 | 0.76769635 |
95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71880682 |
96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70006822 |
97 | Allograft rejection_Homo sapiens_hsa05330 | 0.69079837 |
98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68166139 |
99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.68012729 |
100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67910735 |
101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67089004 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65384758 |
103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65330436 |
104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62116594 |
105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61794674 |
106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60685907 |
107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57984171 |
108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54900149 |
109 | Phagosome_Homo sapiens_hsa04145 | 0.53641798 |
110 | Influenza A_Homo sapiens_hsa05164 | 0.53150165 |
111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52964661 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52265304 |
113 | Tuberculosis_Homo sapiens_hsa05152 | 0.51963670 |
114 | RNA polymerase_Homo sapiens_hsa03020 | 0.51399832 |
115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49019154 |
116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48424702 |
117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48362791 |
118 | Pertussis_Homo sapiens_hsa05133 | 0.47159162 |
119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46919405 |
120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46205316 |
121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42466197 |
122 | Base excision repair_Homo sapiens_hsa03410 | 0.40943508 |
123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39777907 |
124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38899560 |
125 | Lysine degradation_Homo sapiens_hsa00310 | 0.38824015 |
126 | Apoptosis_Homo sapiens_hsa04210 | 0.37893728 |
127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37801947 |
128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37613028 |
129 | Measles_Homo sapiens_hsa05162 | 0.34464523 |
130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30874298 |
131 | Hepatitis C_Homo sapiens_hsa05160 | 0.30060229 |
132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.29598108 |
133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29106811 |
134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28107874 |
135 | Shigellosis_Homo sapiens_hsa05131 | 0.26423541 |
136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.25726353 |
137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23603211 |